Exploring biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab ( <scp>B‐PAD</scp> study)-Reference-Cited by-同舟云学术

Exploring biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab ( B‐PAD study)

Published:2022-12-16 Issue:2 Volume:53 Page:233-238
ISSN:0954-7894
Container-title:Clinical & Experimental Allergy
language:en
Short-container-title:Clin Experimental Allergy

Author:

Nakahara Takeshi¹,Izuhara Kenji²^ORCID,Onozuka Daisuke³^ORCID,Saeki Hidehisa⁴,Nunomura Satoshi²^ORCID,Takenaka Motoi⁵,Matsumoto Mai⁵,Kataoka Yoko⁶,Fujimoto Rai⁶,Kaneko Sakae⁷,Morita Eishin⁷^ORCID,Tanaka Akio⁸,Hide Michihiro⁸,Okano Tatsuro⁹,Miyagaki Tomomitsu⁹,Aoki Natsuko¹⁰,Nakajima Kimiko¹⁰,Ichiyama Susumu⁴,Kido‐Nakahara Makiko¹,Tonomura Kyoko¹¹,Nakagawa Yukinobu¹¹,Tamagawa‐Mineoka Risa¹²^ORCID,Masuda Koji¹²,Takeichi Takuya¹³,Akiyama Masashi¹³,Ishiuji Yozo¹⁴,Katsuta Michie¹⁴,Kinoshita Yuki¹⁵,Tateishi Chiharu¹⁵,Yamamoto Aya¹⁶,Morita Akimichi¹⁶,Matsuda‐Hirose Haruna¹⁷,Hatano Yutaka¹⁷,Kawasaki Hiroshi¹⁸,Tanese Keiji¹⁸,Ohtsuki Mamitaro¹⁹,Kamiya Koji¹⁹,Kabata Yudai²⁰,Abe Riichiro²⁰,Mitsui Hiroshi²¹,Kawamura Tatsuyoshi²¹,Tsuji Gaku¹,Katoh Norito¹²,Furue Masutaka¹

Affiliation:

1. Department of Dermatology Graduate School of Medical Sciences Kyushu University Fukuoka Japan

2. Division of Medical Biochemistry Department of Biomolecular Sciences Saga Medical School Saga Japan

3. Department of Oral Microbe Control Graduate School of Medicine Osaka University Osaka Japan

4. Department of Dermatology Nippon Medical School Tokyo Japan

5. Department of Dermatology Graduate School of Biomedical Sciences Nagasaki University Nagasaki Japan

6. Department of Dermatology Osaka Habikino Medical Center Osaka Japan

7. Department of Dermatology Shimane University Faculty of Medicine Shimane Japan

8. Department of Dermatology Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan

9. Department of Dermatology St. Marianna University School of Medicine Kanagawa Japan

10. Department of Dermatology Kochi Medical School Kochi Japan

11. Department of Dermatology Course of Integrated Medicine Graduate School of Medicine Osaka University Osaka Japan

12. Department of Dermatology Graduate School of Medical Science Kyoto Prefectural University of Medicine Kyoto Japan

13. Department of Dermatology Nagoya University Graduate School of Medicine Aichi Japan

14. Department of Dermatology The Jikei University School of Medicine Tokyo Japan

15. Department of Dermatology Osaka Metropolitan University Graduate School of Medicine Osaka Japan

16. Department of Geriatric and Environmental Dermatology Nagoya City University Graduate School of Medical Sciences Aichi Japan

17. Department of Dermatology Faculty of Medicine Oita University Oita Japan

18. Department of Dermatology School of Medicine Keio University Tokyo Japan

19. Department of Dermatology Jichi Medical University Tochigi Japan

20. Division of Dermatology Niigata University Graduate School of Medical and Dental Sciences Niigata Japan

21. Department of Dermatology Faculty of Medicine University of Yamanashi Yamanashi Japan

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cea.14267

Reference9 articles.

1. Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis

2. Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis

3. Efficacy of Dupilumab for Atopic Dermatitis According to Clinical Course and Clinical Findings: A Multicentre Retrospective Study

4. A Literature Review of Real-World Effectiveness and Safety of Dupilumab for Atopic Dermatitis

5. Atopic dermatitis 2.0: from the clinical phenotype to the molecular taxonomy and stratified medicine

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The ability of biomarkers to assess the severity of atopic dermatitis;Journal of Allergy and Clinical Immunology: Global;2024-02

2. Exploring patient background and biomarkers associated with the development of dupilumab-associated conjunctivitis and blepharitis;Allergology International;2023-12